Novartis launches Innovation Prize for Assistive Tech to encourage new technologies that address unmet needs of the multiple sclerosis community
Dec 09, 2019
Novartis launches Innovation Prize for Assistive Tech to encourage new technologies that address unmet needs of the multiple sclerosis community. The Novartis Innovation Prize: Assistive Tech for Multiple Sclerosis (MS) identifies and embraces technology that aims to improve mobility and daily life for people living with MS.
Applications are open worldwide to the tech community, innovators, design experts, patient advocates – anyone with an idea to make everyday life better for those with MS or mobility-limiting disabilities. The applications will be accepted until January 19th, 2020 at 17:00 ET and the winners will be announced at the SXSW conference in Texas on March 13, 2020. In order to develop their innovation, the first-place winner will receive a prize worth $250,000 and the second-place winner will receive $50,000*
To launch this initiative, Novartis is proud to work with WIRED Brand Lab, alongside other key collaborators such as Techstars, Shift.ms, the National Multiple Sclerosis Society, and more. “Every day, patients with multiple sclerosis (MS) face difficult and unique mobility challenges that can make regular activities such as walking, speaking, and living out comfortable lives extremely difficult,” said John Tsai, Head of Global Drug Development and Chief Medical Officer, Novartis. “Novartis is deeply invested in this community, and it is our hope that through this Innovation Prize, we can help reimagine care for people living with MS by encouraging new technologies addressing some of the challenges faced by those living with MS and their loved ones.”
“A primary fear of many people living with MS is the loss of their independence – from overall mobility and accessibility limitations to an impact on daily activities and employment,” said George Pepper, co-founder and CEO of Shift.ms. “We are excited to see how the Novartis Innovation Prize will stimulate new innovation and drive conversation around improving quality of life for those living with MS and other mobility-limiting conditions.”